This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Inoperable or Recurrent Breast Cancer
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

To investigate of the clinical safety and effectiveness of eribulin mesylate in patients with inoperable or recurrent breast cancer

Provided treatments

  • Drug: Eribulin Mesylate

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01463891. The sponsor of the trial is Eisai Co., Ltd. and it is looking for 963 volunteers for the current phase.
Official trial title:
Post-marketing Surveillance for the Clinical Safety and Effectiveness of Eribulin Mesylate in Patients With Inoperable or Recurrent Breast Cancer